TABLE 2.

Comparison of dermatologic diseases/complaints between the pandemic and pre‐pandemic period

Variables	Pre‐pandemic (March–May 2019) (n = 1165)	Pandemic (March–May 2020) (n = 717)	P value
Acne	283 (23.4%)	141 (19.7%)	.02
Dermatophytosis	114 (9.8%)	51 (7.1%)	.04
Benign neoplasm of the skin	87 (7.5%)	31 (4.3%)	.006
Contact dermatitis	67 (5.8%)	71 (9.9%)	.007
Wart	59 (5.1%)	42 (5.9%)	.45
Psoriasis	52 (4.5%)	21 (2.9%)	.09
Rosacea	51 (4.4%)	19 (2.6%)	.06
Non‐scarring alopecia/hair loss	57 (4.9%)	32 (4.5%)	.67
Nail disorders with/without onychomycosis	54 (4.6%)	33 (4.6%)	.97
Pruritus	37 (3.1%)	34 (4.7%)	.08
Urticaria	30 (2.6%)	18 (2.5%)	.93
Xeroderma	29 (2.5%)	15 (2.1%)	.57
Seborrheic dermatitis	27 (2.3%)	20 (2.8%)	.52
Cutaneous infection and infestation	21 (1.8%)	21 (2.9%)	.10
Melasma/postinflammatory hyperpigmentation	21 (1.8)	8 (1.1%)	.24
Atopic dermatitis	17 (1.5%)	12 (1.2%)	.71
Malign neoplasm of the skin	15 (1.3%)	5 (0.7%)	.22
Aphthous stomatitis	15 (1.3%)	8 (1.1%)	.74
Acne and dermatitis	13 (1.1%)	44 (6.1%)	<.001
Nevus/ephelid/lentigo	13 (1.1%)	4 (0.6%)	.21
Bullous dermatitis	10 (0.9%)	6 (0.8%)	.96
Vitiligo	10 (0.9%)	9 (1.3%)	.52
Actinic keratosis	6 (0.5%)	5 (0.6%)	.61
Behçet's disease	9 (0.8%)	3 (0.4%)	.34
Drug eruption, leukocytoclastic vasculitis and reactive dermatosis	11 (0.9%)	6 (0.8%)	.81
Cicatricial hair loss	0 (0%)	6 (0.8%)	.009
Pityriasis rosea	5 (0.4%)	3 (0.4%)	.97
Lichen planus	5 (0.4%)	9 (1.3%)	.04
Atrophic disorders of the skin, Connective tissue disease	10 (0.9%)	5 (0.7%)	.70
Hidradenitis suppurativa	4 (0.3%)	2 (0.3%)	.80
Herpes simplex infection	9 (0.8%)	9 (1.3%)	.29
Zona zoster infection	12 (1%)	16 (2.2%)	.03
Others	12 (1%)	9 (1.3%)	.65